istradefylline

FDA Drug Profile — NOURIANZ

Drug Details

Generic Name
istradefylline
Brand Names
NOURIANZ
Application Number
NDA022075
Sponsor
Kyowa Kirin, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
ISTRADEFYLLINE

Indications and Usage

1 INDICATIONS AND USAGE NOURIANZ is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes. NOURIANZ is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes ( 1 ).